Hims & Hers shifts US weight loss strategy with Novo Nordisk deal
Hims & Hers is refocusing its US weight loss business and teaming up with Novo Nordisk, prioritizing access to a wider set of FDA-approved GLP-1 drugs.
Hims & Hers is refocusing its US weight loss business and teaming up with Novo Nordisk, prioritizing access to a wider set of FDA-approved GLP-1 drugs.
Veeva Systems is acquiring Ostro for about $100 million. The AI chat platform targets compliant brand websites and engagement insights for life sciences.
Sandoz has launched an azelastine/fluticasone nasal spray in Germany and Switzerland, expanding access to a fixed-dose allergy treatment option.
Dr. Christopher Kirsch (Sandoz/Hexal) has been appointed chair of Pro Biosimilars. Dominic Fister (STADAPHARM) will serve as deputy chair.
Lilly Deutschland has opened an interactive obesity experience at Berlin’s Masumi Space. The installation runs from 2 to 8 March 2026.
Ahead of 23 March, NOWEDA sends an LED truck with its “Apotheken stärken. Jetzt” campaign to several major German cities.
Sandoz and Samsung Bioepis agreed to collaborate on up to five biosimilar assets, starting with an early-stage vedolizumab biosimilar program.
Roche is adding 2,176 NVIDIA Blackwell GPUs to its AI factory. The company says its hybrid-cloud footprint now exceeds 3,500 GPUs.
Point-of-care marketing now spans telehealth and retail settings. Three misconceptions about prescribing, cost focus, and measurement transparency can limit impact.
Sanacorp names Manuel Kuhn as Board member for Trade from 1 July 2026. He succeeds Frank Hennings and will oversee sales, purchasing and mea.